Rein Therapeutics, Inc. · NASDAQ:RNTX
Windsor James Brian bought 25,000 Rein Therapeutics, Inc. shares (Form 4)
Traded Apr 30, 2026 · Filed May 13, 2026
On Apr 30, 2026, Windsor James Brian (Director, See Remarks) bought 25,000 Rein Therapeutics, Inc. shares at US$1.00 for US$25,000, leaving 27,046 shares. Filed May 13, 2026 (Form 4).
- Bought
- 25,000 shares
- Price
- US$1.00
- Value
- US$25,000
- Holding after
- 27,046 shares
- Trading plan
- No
- Role
- Director, See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common stock , $0.001 par value | Buy | 25,000 | US$1.00 | 27,046 | Direct |
Source
Related
- Rein Therapeutics, Inc.
- Windsor James Brian
- Rein Therapeutics, Inc. shareholders
- Schedule 13G/A · Lynwood Capital Management Inc. · Aug 14, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Schedule 13G/A · Voss Capital, LP · Jul 14, 2026
- Form 4 · Von Rickenbach Josef H · May 28, 2026